Canada Heart Disease Statistics 2026 | Deaths, Risk Factors & Key Facts

What is Heart Disease in Canada?

Heart disease is a broad term that encompasses a family of conditions affecting the heart’s structure and function — including ischemic heart disease (coronary artery disease and heart attacks), heart failure, arrhythmias such as atrial fibrillation, structural heart disease, and hypertensive heart disease. In Canada, these conditions represent a sustained and deeply consequential public health crisis. Heart disease is the second leading cause of death in Canada, accounting for approximately 17.7% of all deaths in 2023, and the broader category of cardiovascular disease — which includes stroke, hypertensive conditions, atherosclerosis, and other circulatory system diseases — claimed an estimated 76,962 lives in 2023 alone, according to Statistics Canada data. That translates to a death from heart disease or stroke occurring roughly every seven minutes in Canada, a frequency that the Heart and Stroke Foundation of Canada has used consistently in its annual advocacy to underscore the immediacy and scale of the crisis. The cost burden is equally staggering: cardiovascular disease is the most costly disease in Canada, totalling $21.2 billion annually in combined direct medical costs and indirect lost earnings — a figure that does not include the enormous quality-of-life burden carried by the more than six million Canadians currently living with heart disease or stroke.

What distinguishes the heart disease landscape in Canada in 2026 from prior decades is the tension between the long-run improvement in age-standardized mortality rates — which have fallen by more than 75% over the past six decades, a profound public health achievement — and the emerging deterioration in several behavioural risk factor profiles that underpin future disease risk. The Heart and Stroke Foundation’s February 3, 2026 annual report — described by CEO Doug Roth as a “big picture” assessment of heart and brain risk factors — found that nine in ten Canadians have at least one key modifiable risk factor for heart disease or stroke, a figure that has not improved despite decades of awareness campaigns. The report, drawing on an Ipsos national poll of 2,842 Canadians aged 30–74 conducted in May 2025 and the latest Statistics Canada surveillance data, found that diet, physical activity, and stress management are deteriorating areas, even as smoking rates continue to decline. The data in this article is sourced exclusively from Statistics Canada, PHAC’s heart disease surveillance system (updated February 12, 2026), the Heart and Stroke Foundation of Canada (February 3, 2026 annual report), the Canadian Institute for Health Information (CIHI), and verified peer-reviewed and federal government publications.

Key Facts: Canada Heart Disease Statistics 2026

The following table captures the most essential and current Canada heart disease facts 2026 — drawn from Statistics Canada (February 5, 2026), PHAC surveillance (February 12, 2026), Heart and Stroke Foundation (February 3, 2026), and CIHI.

Data Sources: Statistics Canada — “Heart Disease and Strokes: Two Different Afflictions, One Common Risk Factor” (statcan.gc.ca, February 5, 2026); Heart and Stroke Foundation of Canada — “New Data Provides Big Picture of Heart and Brain Risk Factors” (heartandstroke.ca, press release February 3, 2026); Heart and Stroke Foundation — “Heart Disease in Canada: New Stats and How to Lower Your Risk” (heartandstroke.ca, February 2, 2026); PHAC — “Heart Disease: Monitoring” (canada.ca, updated February 12, 2026); CIHI — “Hospital Stays in Canada, 2023–2024” (cihi.ca, February 20, 2025); CBC News — “Report Urges Canadians to Focus on Health Basics as 80% of Premature Heart Disease and Stroke Preventable” (February 3, 2026); Statista — “Cardiovascular Disease in Canada” (citing Statistics Canada data); Heart and Stroke Foundation — “Connected by the Numbers” (heartandstroke.ca)

These 26 facts map the full scope of heart disease in Canada — from the death toll and prevalence statistics at the top to the behavioural risk factor data that will determine the disease burden of the next generation. The contrast between 57,890 deaths from heart disease alone in 2023 and the simultaneously documented ~80% preventability estimate from the Heart and Stroke Foundation is perhaps the most important single tension in the entire dataset: this is not a disease that Canada lacks the knowledge to prevent, but one where the gap between clinical knowledge and population-level behaviour change remains stubbornly wide. The 6.3% of adults who have ever been diagnosed with heart disease or heart attack — representing over 2.6 million Canadians when applied to the adult population — is a prevalence figure that places heart disease in the same territory as diabetes as a major chronic disease category affecting a meaningful fraction of the working-age and older adult population. The income gradient — 8.8% prevalence in the lowest income quintile versus 5.1% in the highest — documents the social determinants of heart disease as clearly as any clinical study could.

Heart Disease Deaths in Canada 2016–2026

Heart Disease and Cardiovascular Deaths in Canada — Trend

HEART DISEASE DEATHS (2023 Statistics Canada):
  57,890 deaths from heart disease — 2nd leading cause of death
  13,833 deaths from stroke (cerebrovascular) — 4th leading cause
  76,962 total major cardiovascular deaths (all circulatory disease categories)
  = 17.7% of all Canadian deaths in 2023

DEATH RATE TREND (major CVD per 100,000 population):
  2000: 247 per 100,000 |███████████████████████████████████████████████████████████
  2010: ~220 per 100,000|███████████████████████████████████████████████████████
  2015: ~210 per 100,000|██████████████████████████████████████████████████████
  2020: ~200 per 100,000|█████████████████████████████████████████████████████
  2023: ~192 per 100,000|███████████████████████████████████████████████████
                         ─────────────────────────────────────────────────────
                         0     50    100   150   200   247
  DECLINE: −22% in death rate from 2000 to 2023
  60-YEAR DECLINE: More than 75% decline since the 1960s

In 2020: 4× more Canadians died from heart disease or stroke (67,399)
         than from COVID-19 (16,151) — Statistics Canada

Data Sources: Statistics Canada — “Heart Disease and Strokes” (February 5, 2026); Statista — “Major Cardiovascular Diseases Death Rate, Canada 2000–2022/23” (citing Statistics Canada); Statistics Canada — Heart and Stroke Month feature (citing 2020 comparative COVID data); Heart and Stroke Foundation — “Connected by the Numbers” (91,524 in 2016 with VCI; 13% more than cancers); PHAC — Heart Disease Monitoring (February 12, 2026)

The long-run decline in Canadian heart disease mortality is one of the genuine public health success stories of the 20th and early 21st centuries. The more than 75% reduction in the age-standardized death rate from heart disease and stroke since the 1960s — driven by advances in pharmacology (statins, antihypertensives, anticoagulants), emergency cardiac care (defibrillators, PCI procedures, clot-busting drugs), surgical innovations (bypass grafting, valve repair, cardiac implants), and sustained public health education — represents one of the largest reductions in disease-specific mortality ever recorded in a high-income country. The death rate of approximately 192 per 100,000 population in 2023 compared to 247 per 100,000 in 2000 reflects a 22% decline in just 23 years, even as the absolute number of deaths has increased modestly — driven by the aging of the Canadian population, which means a larger share of Canadians is now entering the age brackets where heart disease risk is highest.

The comparison to cancer mortality provides a useful perspective on relative scale. Heart and Stroke Foundation data found that 91,524 Canadians died of heart conditions, stroke, and vascular cognitive impairment in 2016 — 13% more than died of all cancers combined in the same year. Cancer receives substantially more public attention and research fundraising than heart disease in Canada, yet by mortality count, cardiovascular disease remains the larger killer. The 2020 comparison data from Statistics Canada — showing that 67,399 Canadians died of heart disease and stroke versus 16,151 from COVID-19 — made visible during the pandemic what epidemiologists had known for years: that the chronic, non-infectious epidemic of cardiovascular disease kills far more Canadians annually than even the most impactful acute infectious diseases. The 57,890 heart disease deaths in 2023 — equivalent to roughly 158 Canadians per day — represent a burden that remains the single most consequential cause of premature and preventable death in the country.

Cardiovascular Disease Prevalence and Types in Canada 2026

Heart Disease Types and Prevalence in Canada — 2023–24 Data
(PHAC Canadian Chronic Disease Surveillance System / Statistics Canada Feb 2026)

Most common type: ISCHEMIC HEART DISEASE (IHD):
  8.2% of Canadian adults — most common form of heart disease
  Includes coronary artery disease (CAD) and acute myocardial infarction (AMI)

Self-reported heart disease prevalence by province (2023):
  Nova Scotia:                  8.7% — highest
  Newfoundland and Labrador:    8.4%
  Saskatchewan:                 7.5%
  National average:             6.3%
  Alberta:                      5.1% — lowest

Stroke survivors (adults 20+):  ~3% of Canadian adults
  Ages 65+:   3.4% have had a stroke
  Ages 50–64: 1.1%
  Ages 18–34: 0.2%

High blood pressure (hypertension):
  25% of adults aged 20+ = approximately 8.2 million diagnosed Canadians
  New Hypertension Canada guideline threshold: 130/80 mmHg (elevated risk designation)

Diabetes (all ages):
  3.9 million+ Canadians — more than 3× the number in 2000

Data Sources: PHAC — “Heart Disease: Monitoring” (canada.ca, updated February 12, 2026, citing Canadian Chronic Disease Surveillance System 2023–24 data); Statistics Canada — “Heart Disease and Strokes: Two Different Afflictions, One Common Risk Factor” (statcan.gc.ca, February 5, 2026); Heart and Stroke Foundation — “Heart Disease in Canada: New Stats” (February 2, 2026); Heart and Stroke Foundation press release (February 3, 2026) citing Ipsos national poll (May 2025) and Statistics Canada data; CIHI — “Hospital Stays in Canada, 2023–2024” (February 20, 2025)

The prevalence data for cardiovascular disease in Canada in 2026 reveals a disease landscape shaped equally by clinical success (declining mortality rates) and structural vulnerability (rising hypertension, tripling of diabetes, persistent high-risk lifestyle profiles). The 8.2% of adults diagnosed with ischemic heart disease according to PHAC’s Canadian Chronic Disease Surveillance System data for 2023–24 represents a meaningful and monitored chronic disease burden — one that increases in both absolute numbers and in management complexity as the population ages. The geographic gradient in self-reported heart disease — from Nova Scotia (8.7%) and Newfoundland (8.4%) at the high end to Alberta (5.1%) at the low end — reflects a combination of provincial demographic differences (Atlantic provinces have older populations), lifestyle risk factor differences, socioeconomic patterns, and possibly access-to-care differences that affect rates of diagnosis and management. The fact that Alberta’s lower prevalence coincides with its younger population profile — documented in the Alberta Population Statistics 2026 analysis — suggests that aging population structure is a significant driver of the geographic variation.

The income-related gradient in both heart disease and stroke is one of the most policy-relevant findings in the Statistics Canada February 2026 data. The 8.8% heart disease prevalence in the lowest income quintile compared to 5.1% in the highest — a 72% relative difference — and the 3:1 ratio in stroke prevalence between bottom and top income quintiles (2.1% vs. 0.7%) confirm that cardiovascular disease is a disease of socioeconomic disadvantage as well as of biology and behaviour. Lower-income Canadians face higher exposure to environmental stressors, less consistent access to nutritious food, greater occupational physical demands combined with less leisure-time physical activity, and more limited access to timely specialist care — all of which compound cardiovascular risk. The 14.1% heart disease prevalence among people with disabilities — more than double the general adult average — creates a particularly stark picture of compounding disadvantage that current Canadian health policy has not adequately addressed.

Heart Disease Risk Factors in Canada 2026

Key Modifiable Risk Factors for Heart Disease and Stroke in Canada
(Heart & Stroke Foundation Feb 3, 2026 annual report; Statistics Canada; PHAC)

9 IN 10 CANADIANS have at least one modifiable risk factor
~80% of premature heart disease and stroke is PREVENTABLE

MEDICAL RISK FACTORS:
  Hypertension:     25% of adults (8.2M diagnosed; new threshold 130/80 mmHg)
  Diabetes:         3.9M+ Canadians (3× increase since 2000)
  High cholesterol: Major controllable risk factor

LIFESTYLE RISK FACTORS:
  Poor diet:        ~8 in 10 Canadians eat fruits/vegetables <5 times/day (StatsCan)
  Physical activity: Insufficient PA widespread across adult population
  Smoking/vaping:   ~11% smoke daily or occasionally (2024) — declining but persistent
  Obesity:          ~31% of Canadians classified as obese (2024)
  Stress:           Flagged as worsening trend in Heart & Stroke 2026 report
  Sleep:            Inadequate sleep — documented emerging risk factor

NON-MODIFIABLE RISK FACTORS:
  Genetics:         ~50% of dying-from-heart-disease risk is genetic
  Age:              Risk increases with age; IHD becomes important at 45 (men), 55 (women)
  Sex:              Men: 7.9% prevalence; Women: 4.7% (but risk converges post-menopause)
  Indigenous status: Settler colonialism created conditions for wide health disparities

Data Sources: Heart and Stroke Foundation of Canada — press release “New Data Provides Big Picture of Heart and Brain Risk Factors” (newswire.ca, February 3, 2026); Heart and Stroke Foundation — “Heart Disease in Canada: New Stats and How to Lower Your Risk” (heartandstroke.ca, February 2, 2026); Heart and Stroke Foundation — “Condition Risk Factors” (heartandstroke.ca); CBC News — “Report Urges Canadians to Focus on Health Basics” (February 3, 2026); PHAC — Heart Disease Monitoring (February 12, 2026); Statista — Cardiovascular Disease in Canada (citing Statistics Canada 2024 smoking and obesity data)

The risk factor profile for heart disease in Canada in 2026 is a study in both progress and persistent vulnerability. The unambiguous good news is smoking: the daily or occasional smoking rate of approximately 11% in 2024 — down from roughly 25% in the early 2000s — represents a genuine population-level behaviour change that has materially reduced cardiovascular risk and is one of the primary contributors to the long-run mortality decline. But the trajectory on dietary quality is moving in the wrong direction: the Heart and Stroke Foundation’s reliance on Statistics Canada data showing approximately 8 in 10 Canadians eating fruits and vegetables fewer than five times per day confirms that the nutritional risk factor — which underpins blood pressure, cholesterol, weight management, and blood sugar — is at a population level far below what clinical guidelines recommend. The ~31% obesity rate in Canada in 2024, combined with the explosive growth in diabetes to 3.9 million Canadians (more than triple the 2000 figure), creates compounding cardiovascular risk that pharmacological intervention can partially manage but cannot eliminate.

The genetics finding from the Heart and Stroke Foundation’s 2026 report is clinically important and often misunderstood by the public: approximately 50% of the risk of dying from heart disease is genetic, meaning that individual behaviour change alone cannot eliminate cardiovascular risk for those with high genetic loading. Family history — having a parent or sibling with early heart disease or stroke — is both a direct genetic signal and a proxy for inherited lifestyle patterns, creating a dual risk pathway that clinical screening can identify but not erase. The Hypertension Canada 2026 guideline update — redefining high blood pressure as ≥130/80 mmHg rather than the previous ≥140/90 mmHg — immediately expanded the number of Canadians classified as hypertensive, a definitional change with significant implications: more Canadians will now be advised to modify lifestyle or begin medication, the 8.2 million already diagnosed will grow, and the healthcare system will face increased demand for hypertension management that existing primary care capacity may struggle to absorb. The foundation’s recommendation is straightforward — “know your numbers, check your blood pressure regularly” — but execution at the population level requires clinical infrastructure that many underserved communities cannot currently access.

Heart Disease Hospitalizations and Healthcare System Impact in Canada 2026

Heart Disease Hospitalization Burden in Canada
(CIHI Hospital Stays 2023–24; PHAC; Canadian Journal of Cardiology; PMC)

CIHI Hospital Stays 2023–2024 (released February 20, 2025):
  Total acute inpatient hospitalizations: 3.05 million
  HEART FAILURE = 3rd most common reason for hospitalization
  Average length of stay (heart failure): 9.6 days

HEART FAILURE SPECIFIC DATA (CIHI DAD; peer-reviewed studies):
  Heart failure hospitalization rate: 216 per 100,000 population (age-adjusted)
  30-day all-cause readmission rate: ~20.6% (nationally stable across years)
  HF average LOS: 9.6 days (CIHI 2023–24)
  Comorbidities per HF admission: Average 3.9 (IHD, Afib, diabetes, renal failure)

MAJOR CVD HOSPITALIZATIONS:
  >1 in 10 hospitalizations in Canada for heart conditions / stroke / VCI
  2.6 million hospitalizations 2007–2017 involved heart / stroke / VCI
  HF hospitalizations increased: 43,114 (2010/11) → 54,743 (2018/19) +27%

COST OF CVD HOSPITALIZATIONS:
  Heart failure hospitalization costs rising — projected to 2039/40 (PMC 2025)
  Cardiovascular disease total cost: $21.2 billion/year (direct + indirect)
  Stroke cost alone: $3.6 billion/year

Data Sources: CIHI — “Hospital Stays in Canada, 2023–2024” (cihi.ca, February 20, 2025); PMC — “The State of Heart Failure Care in Canada” (pmc.ncbi.nlm.nih.gov, citing CIHI Hospital Morbidity Database); PMC — “Economic Burden of Heart Failure Hospitalizations in Canada: A Population-Based Study” (CJC Open, accepted November 2024, published March 2025); PubMed — “Comorbidities and Mortality Associated with Hospitalized Heart Failure in Canada”; Heart and Stroke Foundation — “Connected by the Numbers” (heartandstroke.ca); PHAC — Heart Disease Monitoring (February 12, 2026)

The hospitalization burden of heart disease in Canada is one of the most consistently documented and most persistently challenging dimensions of the cardiovascular crisis. Heart failure’s position as the third most common reason for hospitalization in Canada — behind only childbirth and COPD/bronchitis, according to CIHI’s 2023–24 data — reflects the sheer clinical severity of the condition: when heart failure decompensates, it almost always requires inpatient care, the average length of stay of 9.6 days represents nearly a full week more than the average birth, and the 20.6% 30-day readmission rate — stable for over a decade at that level, despite multiple evidence-based care initiatives — signals that the healthcare system is managing acute episodes without consistently addressing the underlying trajectory of the disease. The +27% increase in heart failure hospitalization episodes between 2010/11 and 2018/19 (from 43,114 to 54,743) does not reflect a worsening of per-patient risk but the expansion of the older adult population — an aging trajectory that will continue pushing absolute hospitalization numbers upward regardless of improvements in per-capita disease management.

The economic magnitude of cardiovascular disease hospitalization is captured in the Heart and Stroke Foundation’s figure of $21.2 billion annually in combined direct and indirect costs — a number that predates several years of healthcare cost inflation and almost certainly understates the current burden. The stroke cost alone of $3.6 billion per year in physician services, hospital costs, and lost wages places it as one of the most economically damaging single conditions in Canadian healthcare. The PMC study on economic burden of heart failure hospitalizations, drawing on CIHI DAD data through 2018/19 and projecting to 2039/40, found that hospitalization costs for heart failure will continue rising as the population ages — a finding that is already being borne out in the growing absolute hospitalization numbers documented in the CIHI data. The 3.9 average comorbidities per heart failure admission — most commonly chronic ischemic heart disease, atrial fibrillation, diabetes, and renal failure — creates clinical complexity that drives longer stays, higher costs, and more challenging discharge planning across a healthcare system already operating at elevated occupancy.

Heart Disease by Demographics and Geography in Canada 2026

Heart Disease — Demographic and Geographic Patterns (Canada 2023–26)
(Statistics Canada Feb 5, 2026; PHAC Feb 12, 2026; Heart & Stroke Foundation)

BY SEX:
  Men:    7.9% heart disease prevalence (vs. 4.7% women)
  Men:    Higher hospitalization AND death rates in all age groups
  Women:  Risk increases at menopause; more women die of heart disease total (live longer)
  Women:  Face distinct risk factors at reproductive age, menopause, post-menopause

BY AGE:
  Ages 18–34: stroke prevalence 0.2%
  Ages 50–64: stroke prevalence 1.1%
  Ages 65+:   stroke prevalence 3.4%
  IHD becomes important for men at age 45; for women at age 55 (clinical guideline)
  Congestive heart failure: dramatically higher admission rates over age 75

BY PROVINCE (heart disease prevalence):
  Nova Scotia:              8.7% ← highest
  Newfoundland and Labrador: 8.4%
  Saskatchewan:             7.5%
  NATIONAL AVERAGE:         6.3%
  Alberta:                  5.1% ← lowest

BY INCOME:
  Bottom 20%: 8.8% heart disease; 2.1% stroke
  Top 20%:    5.1% heart disease; 0.7% stroke
  → 72% relative higher risk for lowest vs highest income (heart disease)
  → 3× relative higher risk for lowest vs highest income (stroke)

Data Sources: Statistics Canada — “Heart Disease and Strokes: Two Different Afflictions, One Common Risk Factor” (February 5, 2026); PHAC — “Heart Disease: Monitoring” (canada.ca, updated February 12, 2026); Heart and Stroke Foundation — “Heart Disease in Canada: New Stats” (February 2, 2026); Heart and Stroke Foundation press release (February 3, 2026)

The demographic and geographic distribution of heart disease in Canada in 2026 documents a condition whose burden is profoundly unequal and whose inequality reflects the social determinants of health as much as the biological ones. The men-to-women prevalence ratio of 7.9% to 4.7% has been consistent across all NHIS-equivalent Canadian surveys for decades, but it requires careful interpretation: it reflects earlier biological onset of clinically significant heart disease in men, not lower ultimate impact on women. Because women live longer than men, the total number of heart disease-related deaths is actually similar across sexes — women simply accumulate their cardiovascular risk later in life, concentrated in the post-menopausal years when the cardioprotective effects of estrogen are withdrawn and risk factors including blood pressure, cholesterol, and abdominal fat distribution converge toward men’s profiles. The Heart and Stroke Foundation’s February 2026 annual report gave specific attention to women’s distinct risk factors — including pregnancy-related conditions, use of oral contraceptives, premature menopause, and autoimmune conditions more common in women — as underrecognized dimensions of cardiovascular risk that clinical practice has historically underweighted.

The province-level data from Statistics Canada’s February 5, 2026 analysis positions the Atlantic provinces as the highest-burden region for heart disease by prevalence — a pattern consistent with every prior wave of surveillance data and attributable to a combination of older average population age, historically higher smoking rates (now declining), lower average household incomes, and rural geography that creates barriers to both primary prevention and timely specialist care. Nova Scotia’s 8.7% prevalence is nearly 70% higher than Alberta’s 5.1% — a gap that cannot be explained by lifestyle alone and reflects both structural demographic differences and the long-run effects of socioeconomic and access disparities that compound over decades. The Indigenous peoples’ elevated cardiovascular risk — acknowledged explicitly in the Heart and Stroke Foundation’s 2026 report as a consequence of “settler colonialism creating conditions that have led to wide disparities in health outcomes” — represents the most deeply structural and historically entrenched dimension of Canada’s heart disease inequality, and one that targeted clinical intervention, without parallel investment in social determinants, cannot sustainably address.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE